Apoptosis-related protein-1 acts as a tumor suppressor in cholangiocarcinoma cells by inducing cell cycle arrest via downregulation of cyclin-dependent kinase subunits

Zheng,Jianyong; Li,Qinlong; Wang,Weihua; Wang,Yingmei; Fu,Xin; Wang,Wenyong; Fan,Linni; Yan,Wei

doi:10.3892/or.2015.4422

Apoptosis-related protein-1 acts as a tumor suppressor in cholangiocarcinoma cells by inducing cell cycle arrest via downregulation of cyclin-dependent kinase subunits

Authors:
- Jianyong Zheng
- Qinlong Li
- Weihua Wang
- Yingmei Wang
- Xin Fu
- Wenyong Wang
- Linni Fan
- Wei Yan
View Affiliations

Affiliations: Department of Gastrointestinal Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China, State Key Laboratory of Cancer Biology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, P.R. China
Published online on: November 16, 2015 https://doi.org/10.3892/or.2015.4422
Pages: 809-816

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cholangiocarcinoma, a malignancy arising from the biliary tract, is associated with high mortality due to the late diagnosis and lack of effective therapeutic approaches. Our knowledge of the molecular alterations during the carcinogenesis of cholangiocarcinoma is limited. Previous study suggests that apoptosis-related protein-1 (Apr-1) is involved in cancer cell proliferation and survival. In the present study, we first detected the expression pattern of Apr-1 in human cholangiocarcinoma tissues and the effects of forced Apr-1 expression on cell proliferation and cell cycle progression. Cell cycle gene array analysis was used to identify downstream molecules that were regulated by Apr-1, and their expression levels were further evaluated in human cholangiocarcinoma tissues. We showed that Apr-1 expression was downregulated in human cholangiocarcinoma tissues. Forced expression of Apr-1 inhibited cell proliferation of cholangiocarcinoma cell line QBC939 and induced G2/M phase arrest. Downregulation of cell cycle-related genes cyclin-dependent kinase (Cdk) 2, and cyclin-dependent kinase subunits (Cks) 1 and 2 was involved in Apr-1-induced cell cycle arrest. Furthermore, we found that Cdk2 and Cks1/2 expression levels were elevated in human cholangiocarcinoma tissues. Taken together, our data showed that Apr-1 plays a crucial role in cell proliferation by controlling cell cycle progression, implying a tumor-suppressor function of Apr-1 in cholangiocarcinoma carcinogenesis. Thus, the present study provides a rationale to further study the underlying mechanisms of Apr-1 downregulation in cholangiocarcinoma for exploring potential diagnostic and therapeutic targets.

View Figures

View References

1	Olnes MJ and Erlich R: A review and update on cholangiocarcinoma. Oncology. 66:167–179. 2004. View Article : Google Scholar : PubMed/NCBI
2	Sandhu DS, Shire AM and Roberts LR: Epigenetic DNA hypermethylation in cholangiocarcinoma: Potential roles in pathogenesis, diagnosis and identification of treatment targets. Liver Int. 28:12–27. 2008. View Article : Google Scholar
3	Razumilava N and Gores GJ: Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
4	Rizvi S and Gores GJ: Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology. 145:1215–1229. 2013. View Article : Google Scholar : PubMed/NCBI
5	Zhu F, Yan W, Zhao ZL, Chai YB, Lu F, Wang Q, Peng WD, Yang AG and Wang CJ: Improved PCR-based subtractive hybridization strategy for cloning differentially expressed genes. Biotechniques. 29:310–313. 2000.PubMed/NCBI
6	Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T and Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res. 61:5544–5551. 2001.PubMed/NCBI
7	Barker PA and Salehi A: The MAGE proteins: Emerging roles in cell cycle progression, apoptosis, and neurogenetic disease. J Neurosci Res. 67:705–712. 2002. View Article : Google Scholar : PubMed/NCBI
8	Bertrand M, Huijbers I, Chomez P and De Backer O: Comparative expression analysis of the MAGED genes during embryogenesis and brain development. Dev Dyn. 230:325–334. 2004. View Article : Google Scholar : PubMed/NCBI
9	Sang M, Wang L, Ding C, Zhou X, Wang B, Wang L, Lian Y and Shan B: Melanoma-associated antigen genes - an update. Cancer Lett. 302:85–90. 2011. View Article : Google Scholar
10	Saburi S, Nadano D, Akama TO, Hirama K, Yamanouchi K, Naito K, Tojo H, Tachi C and Fukuda MN: The trophinin gene encodes a novel group of MAGE proteins, magphinins, and regulates cell proliferation during gametogenesis in the mouse. J Biol Chem. 276:49378–49389. 2001. View Article : Google Scholar : PubMed/NCBI
11	Salehi AH, Roux PP, Kubu CJ, Zeindler C, Bhakar A, Tannis LL, Verdi JM and Barker PA: NRAGE, a novel MAGE protein, interacts with the p75 neurotrophin receptor and facilitates nerve growth factor-dependent apoptosis. Neuron. 27:279–288. 2000. View Article : Google Scholar : PubMed/NCBI
12	Selimovic D, Sprenger A, Hannig M, Haïkel Y and Hassan M: Apoptosis related protein-1 triggers melanoma cell death via interaction with the juxtamembrane region of p75 neurotrophin receptor. J Cell Mol Med. 16:349–361. 2012. View Article : Google Scholar
13	Yan W, Li Q and Zhu F: Apoptosis-related genes cloned by improved subtractive hybridization. Zhonghua Zhong Liu Za Zhi. 23:193–195. 2001.In Chinese.
14	Yan W, Wang W-L, Zhu F, Cheng SQ, Li QL, Wang L and Wang CJ: Cloning and subcellular localization of apr-1 - a new gene of tumor specific antigen family. Ai Zheng. 24:129–134. 2005.In Chinese. PubMed/NCBI
15	Zhang Y, Li Q, Zhu F, Cui J, Li K, Li Q, Wang R, Wang W, Wang W and Yan W: Subcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissues. J Exp Clin Cancer Res. 28:1112009. View Article : Google Scholar : PubMed/NCBI
16	Zhang Y, Li Q, Huang W, Zhang J, Han Z, Wei H, Cui J, Wang Y and Yan W: Increased expression of apoptosis-related protein 3 is highly associated with tumorigenesis and progression of cervical squamous cell carcinoma. Hum Pathol. 44:388–393. 2013. View Article : Google Scholar
17	Robertson S, Hyder O, Dodson R, Nayar SK, Poling J, Beierl K, Eshleman JR, Lin MT, Pawlik TM and Anders RA: The frequency of KRAS and BRAF mutations in intrahepatic cholangiocarcinomas and their correlation with clinical outcome. Hum Pathol. 44:2768–2773. 2013. View Article : Google Scholar : PubMed/NCBI
18	Yothaisong S, Dokduang H, Techasen A, Namwat N, Yongvanit P, Bhudhisawasdi V, Puapairoj A, Riggins GJ and Loilome W: Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. Tumour Biol. 34:3637–3648. 2013. View Article : Google Scholar : PubMed/NCBI
19	Maemura K, Natsugoe S and Takao S: Molecular mechanism of cholangiocarcinoma carcinogenesis. J Hepatobiliary Pancreat Sci. 21:754–760. 2014. View Article : Google Scholar : PubMed/NCBI
20	van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A and Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643–1647. 1991. View Article : Google Scholar : PubMed/NCBI
21	Morgan DO: Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol. 13:261–291. 1997. View Article : Google Scholar : PubMed/NCBI
22	Pagano M, Pepperkok R, Lukas J, Baldin V, Ansorge W, Bartek J and Draetta G: Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J Cell Biol. 121:101–111. 1993. View Article : Google Scholar : PubMed/NCBI
23	Merrick KA, Larochelle S, Zhang C, Allen JJ, Shokat KM and Fisher RP: Distinct activation pathways confer cyclin-binding specificity on Cdk1 and Cdk2 in human cells. Mol Cell. 32:662–672. 2008. View Article : Google Scholar : PubMed/NCBI
24	Tane S and Chibazakura T: Cyclin A overexpression induces chromosomal double-strand breaks in mammalian cells. Cell Cycle. 8:3900–3903. 2009. View Article : Google Scholar : PubMed/NCBI
25	Wheeler LW, Lents NH and Baldassare JJ: Cyclin A-CDK activity during G1 phase impairs MCM chromatin loading and inhibits DNA synthesis in mammalian cells. Cell Cycle. 7:2179–2188. 2008. View Article : Google Scholar : PubMed/NCBI
26	Hayles J, Beach D, Durkacz B and Nurse P: The fission yeast cell cycle control gene cdc2: Isolation of a sequence suc1 that suppresses cdc2 mutant function. Mol Gen Genet. 202:291–293. 1986. View Article : Google Scholar : PubMed/NCBI
27	Richardson HE, Stueland CS, Thomas J, Russell P and Reed SI: Human cDNAs encoding homologs of the small p34^Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe. Genes Dev. 4:1332–1344. 1990. View Article : Google Scholar : PubMed/NCBI
28	Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M and Hershko A: The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. Nat Cell Biol. 3:321–324. 2001. View Article : Google Scholar : PubMed/NCBI
29	Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW and Reed SI: A CDK-independent function of mammalian Cks1: Targeting of SCF^Skp2 to the CDK inhibitor p27^Kip1. Mol Cell. 7:639–650. 2001. View Article : Google Scholar : PubMed/NCBI
30	Frontini M, Kukalev A, Leo E, Ng YM, Cervantes M, Cheng CW, Holic R, Dormann D, Tse E, Pommier Y, et al: The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment. Dev Cell. 23:356–370. 2012. View Article : Google Scholar : PubMed/NCBI
31	Spruck CH, de Miguel MP, Smith APL, Ryan A, Stein P, Schultz RM, Lincoln AJ, Donovan PJ and Reed SI: Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis. Science. 300:647–650. 2003. View Article : Google Scholar : PubMed/NCBI
32	Rother K, Dengl M, Lorenz J, Tschöp K, Kirschner R, Mössner J and Engeland K: Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73. FEBS Lett. 581:1166–1172. 2007. View Article : Google Scholar : PubMed/NCBI
33	Liberal V, Martinsson-Ahlzén HS, Liberal J, Spruck CH, Widschwendter M, McGowan CH and Reed SI: Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins. Proc Natl Acad Sci USA. 109:2754–2759. 2012. View Article : Google Scholar :
34	Shen DY, Fang ZX, You P, Liu PG, Wang F, Huang CL, Yao XB, Chen ZX and Zhang ZY: Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. Liver Int. 30:119–125. 2010. View Article : Google Scholar
35	Chen R, Feng C and Xu Y: Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression. J Int Med Res. 39:533–540. 2011. View Article : Google Scholar : PubMed/NCBI
36	Kang MA, Kim J-T, Kim JH, Kim SY, Kim YH, Yeom YI, Lee Y and Lee HG: Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer. J Cancer Res Clin Oncol. 135:761–769. 2009. View Article : Google Scholar
37	Tanaka F, Matsuzaki S, Mimori K, Kita Y, Inoue H and Mori M: Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer. Int J Oncol. 39:361–372. 2011.PubMed/NCBI
38	Menghi F, Orzan FN, Eoli M, Farinotti M, Maderna E, Pisati F, Bianchessi D, Valletta L, Lodrini S, Galli G, et al: DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence. Oncologist. 16:1440–1450. 2011. View Article : Google Scholar : PubMed/NCBI
39	Shen DY, Zhan YH, Wang QM, Rui G and Zhang ZM: Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma. Liver Int. 33:137–148. 2013. View Article : Google Scholar
40	Cardozo T and Pagano M: The SCF ubiquitin ligase: Insights into a molecular machine. Nat Rev Mol Cell Biol. 5:739–751. 2004. View Article : Google Scholar : PubMed/NCBI
41	Weissman AM: Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol. 2:169–178. 2001. View Article : Google Scholar : PubMed/NCBI
42	Frescas D and Pagano M: Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: Tipping the scales of cancer. Nat Rev Cancer. 8:438–449. 2008. View Article : Google Scholar : PubMed/NCBI
43	Hashimoto N, Yachida S, Okano K, Wakabayashi H, Imaida K, Kurokohchi K, Masaki T, Kinoshita H, Tominaga M, Ajiki T, et al: Immunohistochemically detected expression of p27^Kip1 and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Ann Surg Oncol. 16:395–403. 2009. View Article : Google Scholar